Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Monnier

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsT Le Chevalier, D Brisgand, J Y Douillard, et al.
ACS Nano|March 12, 2014
Insertion of nanoparticle clusters into vesicle bilayersCécile Bonnaud, Christophe A Monnier, Davide Demurtas, et al.
Pathologie-Biologie|November 1, 1992
[Intraperitoneal recombinant gamma interferon (RU 42369) efficacy in ovarian carcinomas. European BRM Study Group]J P Guastalla, E Pujade-Lauraine, N Colombo, et al.
Journal of the American Medical Directors Association|December 4, 2019
Antibiotic Stewardship in European Nursing Homes: Experiences From the Netherlands, Norway, Poland, and SwedenLaura W Van Buul, Annelie A Monnier, Pär-Daniel Sundvall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2018
Ensuring Antibiotic Development, Equitable Availability, and Responsible Use of Effective Antibiotics: Recommendations for Multisectoral ActionAnnelie A Monnier, Jeroen Schouten, Gianpiero Tebano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III randomized trial of amifostine as a radioprotector in head and neck cancerD M Brizel, T H Wasserman, M Henke, et al.
Nanoscale|June 25, 2016
A lock-in-based method to examine the thermal signatures of magnetic nanoparticles in the liquid, solid and aggregated statesC A Monnier, M Lattuada, D Burnand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trialH Roché, P Kerbrat, J Bonneterre, et al.
Bulletin Du Cancer|February 1, 1993
[Intraperitoneal administration of interferon gamma. An efficient adjuvant to the chemotherapy of ovarian cancers. Apropos of an European study of 108 patients]E Pujade-Lauraine, J P Guastella, N Colombo, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Seminars in Oncology|October 1, 1994
A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysisT Le Chevalier, J L Pujol, J Y Douillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1994
Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsT Le Chevalier, D Brisgand, J Y Douillard, et al.
ACS Nano|March 12, 2014
Insertion of nanoparticle clusters into vesicle bilayersCécile Bonnaud, Christophe A Monnier, Davide Demurtas, et al.
Pathologie-Biologie|November 1, 1992
[Intraperitoneal recombinant gamma interferon (RU 42369) efficacy in ovarian carcinomas. European BRM Study Group]J P Guastalla, E Pujade-Lauraine, N Colombo, et al.
Journal of the American Medical Directors Association|December 4, 2019
Antibiotic Stewardship in European Nursing Homes: Experiences From the Netherlands, Norway, Poland, and SwedenLaura W Van Buul, Annelie A Monnier, Pär-Daniel Sundvall, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2018
Ensuring Antibiotic Development, Equitable Availability, and Responsible Use of Effective Antibiotics: Recommendations for Multisectoral ActionAnnelie A Monnier, Jeroen Schouten, Gianpiero Tebano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Phase III randomized trial of amifostine as a radioprotector in head and neck cancerD M Brizel, T H Wasserman, M Henke, et al.
Nanoscale|June 25, 2016
A lock-in-based method to examine the thermal signatures of magnetic nanoparticles in the liquid, solid and aggregated statesC A Monnier, M Lattuada, D Burnand, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trialH Roché, P Kerbrat, J Bonneterre, et al.
Bulletin Du Cancer|February 1, 1993
[Intraperitoneal administration of interferon gamma. An efficient adjuvant to the chemotherapy of ovarian cancers. Apropos of an European study of 108 patients]E Pujade-Lauraine, J P Guastella, N Colombo, et al.
Pageof 16